June is the Richard W. Vague Professor in Immunotherapy in the department of Pathology and Laboratory Medicine and the Perelman School of Medicine at the University of Pennsylvania and director of Translational Research in Penn's Abramson Cancer Center.
Michael Kalos, Ph.D., an adjunct associate professor in the department of Pathology and Laboratory Medicine in the Perelman School of Medicine at Penn, is co-first author on the study.
The research was supported by grants from National Institutes of Health, the Leukemia and Lymphoma Society, and the Alliance for Cancer Gene Therapy.
Lynette Summerill is an award-winning writer and Scuba enthusiast who lives in San Diego with her husband and two beach loving dogs. In addition to writing about cancer-related issues for EmpowHER, her work has been seen in publications around the world.
Grupp, M.D. Stephan A. et al. “Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia”, Published online March 25, 2013DOI: 10.1056/NEJMoa1215134
“T-cell therapy eradicates an aggressive leukemia in 2 children” Holly Auer. University of Pennsylvania press release. 25 March, 2013.
Reviewed March 26, 2013
by Michele Blacksberg RN
Edited by Jody Smith